Achromobacter Species: An Emerging Cause of Community-Onset Bloodstream Infections

Achromobacter xylosoxidans and Stenotrophomonas maltophilia: Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients’ Lung

(2021) Quentin Menetrey et al.   Genes

Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study

(2021) Melissa C. MacKinnon et al.   BMC INFECTIOUS DISEASES

Achromobacter spp. Surgical Site Infections: A Systematic Review of Case Reports and Case Series

(2021) Eve Ronin et al.   Microorganisms

Achromobacter Infections and Treatment Options

(2020) Burcu Isler et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Achromobacter spp. healthcare associated infections in the French West Indies: a longitudinal study from 2006 to 2016

(2019) Karine Marion-Sanchez et al.   BMC INFECTIOUS DISEASES

Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis

(2015) Michael D. Parkins et al.   Journal of Cystic Fibrosis

Factors Influencing Acquisition of Burkholderia cepacia Complex Organisms in Patients with Cystic Fibrosis

(2013) K. A. Ramsay et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Defining the epidemiology of bloodstream infections: the ‘gold standard’ of population-based assessment

(2012) K. B. LAUPLAND   EPIDEMIOLOGY AND INFECTION

Achromobacter xylosoxidans, an emerging pathogen in catheter-related infection in dialysis population causing prosthetic valve endocarditis: a case report and review of literature

(2011) M.S. Ahmed et al.   CLINICAL NEPHROLOGY

Development of a Novel Electronic Surveillance System for Monitoring of Bloodstream Infections

(2010) Jenine Leal et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY